Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials

Visa sponsorship

#3,811 of 8,228 sponsors
2 ▲ 100%
H-1B filings in 12 months
1
Green card filings
$121k
Median offered salary
Who they sponsor
Compliance officers
1
Bioengineers and biomedical engineers
1
The salary offered for each occupationVisa pass · 90 credits
In the register as Sight Sciences, Inc., Menlo Park, CA (+1 more)
Other sponsors in the same field
Alert me
US Department of Labor · latest filing Mar 6, 2026 · Visa details by country

Overview

We aim to provide eyecare providers with transformative, clinically-proven therapies that are intuitive, less invasive, and more intelligent.

News

News YahooFinance 26 days ago
Sight Sciences (SGHT) Stock Gets Fair Value Boost After Analyst Target Increases
The recent update lifts Sight Sciences' fair value reference point from US$8.40 to US$9.40, giving investors a fresh anchor for thinking about upside and downside around the stock. That change aligns with research that has become more constructive, even a
Read more
Report
News markets.businessinsider.com 1 month ago
Sight Sciences to Debut the OMNI Ultra Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual...
MENLO PARK, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company f...
Read more
Report
News YahooFinance 1 month ago
Sight Sciences to Debut the OMNI Ultra Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting
MENLO PARK, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, interventional technologies intended to transform eye care
Read more
Report
News YahooFinance 2 years ago
Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations
New leadership appointments strengthen Sight Sciences' commitment to advancing innovative eyecare solutions and supporting scalable operations and growthMENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (
Read more
Report
Award healio.com 2 years ago
Sight Sciences awarded $34 million in patent infringement case against Alcon
Sight Sciences received a positive jury trial verdict of $34 million in a patent infringement case against Alcon and its Hydrus microstent, according to a press release.
Read more
Report
Blog 2 years ago
Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office
PDF Version MENLO PARK, Calif., March 30, 2023 (GLOBE NEWSWIRE) - Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences," or the "Company"), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patie
Read more
Report
Show more news

People

Paul Badawi
Executive Officer, Director
Jesse Selnick
Executive Officer
Stephen Thau
Executive Officer
Staffan Encrantz
Director
Mack Hicks
Director
David Badawi
Director
Carter Meyer
Director
Valeska Schroeder
Director
Erica Rogers
Director
Andrew Offer
Director
Don Zurbay
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Growth

Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Administrative
100% ▲

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Menlo Park United States
HQ
200-500 est. staff

Financials

Total raised
$103.9M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2020 $23.2M Details
Venture - Series Unknown 2020 $30.2M Details
Venture - Series Unknown 2019 $30.7M Details
Venture - Series Unknown 2017 $19.7M Details